Acutus Medical, Inc.AFIBNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR+200.2%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+200.2%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
27x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2024 | 10.27% |
| Q3 2024 | 4.18% |
| Q2 2024 | -33.32% |
| Q1 2024 | 127.32% |
| Q4 2023 | -264.34% |
| Q3 2023 | -19.95% |
| Q2 2023 | 107.60% |
| Q1 2023 | -52.66% |
| Q4 2022 | -2.40% |
| Q3 2022 | -31.56% |
| Q2 2022 | -1.68% |
| Q1 2022 | -9.33% |
| Q4 2021 | 0.38% |
| Q3 2021 | 1.31% |
| Q2 2021 | -4.01% |
| Q1 2021 | 7.17% |
| Q4 2020 | -4.23% |
| Q3 2020 | 73.51% |
| Q2 2020 | -10.85% |
| Q1 2020 | 30.40% |
| Q4 2019 | -1.62% |
| Q3 2019 | 15.17% |
| Q2 2019 | 69.24% |
| Q1 2019 | 0.00% |